Key result
Inflammatory biomarkers hsCRP and IL-6 independently associate with cardiovascular risk and improve risk stratification.
Why the study?
There is growing interest in the role of inflammatory biomarkers in cardiovascular risk-stratification, but their correlation with cardiovascular risk profiles and the utility of IL-6 alone required investigation.
Cross-Sectional (n=75)
No
Inflammatory biomarkers, particularly hsCRP and IL-6, provide statistically significant added predictive value to traditional risk factors in cardiovascular risk stratification for patients with moderate to high CV risk.
May enhance CV risk stratification beyond traditional factors; hypothesis-generating and requires prospective validation.
No takes yet. Share an insight, caveat, or question.
Vavlukis et al. (2020) conducted a cross-sectional in Moderate to high cardiovascular risk (n=75). Inflammatory biomarkers assessment was evaluated on Independent association of inflammatory markers with total estimated EUROSCORE risk. Inflammatory biomarkers, particularly hsCRP and IL-6, demonstrated statistically significant independent associations with cardiovascular risk and provided added predictive power in risk stratification.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: